Investors are disappointed with the company's latest clinical update.
Compare TBIO Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
Translate Bio, Inc.
News & Analysis: Translate Bio, Inc.
Big drugmakers could be attracted to these smaller players with promising pipelines.
Great efficacy results for mRNA COVID-19 vaccines so far could bode well for these three stocks.
The market leader in flu vaccines is trailing in the race to find an effective coronavirus vaccine.
Don't put all your eggs into one platform of vaccine development.
If coronavirus vaccine development efforts are a race, then pharmaceutical companies will need to hurdle more than clinical trials to be successful.
The clinical-stage vaccine developer, which is working on a COVID-19 vaccine candidate, announced it's selling more shares to the public.
Major market benchmarks settled for modest gains on Tuesday.
The company's collaboration with Sanofi is shifting into a higher gear.
Biotech and big pharma are putting vaccines using messenger RNA to the coronavirus test.